Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern

Immunity(2022)10.1016/j.immuni.2022.01.001Source: DataRank Database

mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern is a research paper published in Immunity (2022). On theSindex it has a DataRank of 0. It has been cited 126 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access126 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (34 grants)Impact (FWCI 11.35)OA: hybridTopics (83)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Stephanie Fischinger ORCID,Deniz Cizmeci ORCID,Yannic C. Bartsch ORCID,Jaewon Kang ORCID,John S. Burke ORCID

Live enrichment

PubMed:35090580 PMC:PMC8733218 OpenAlex:https://openalex.org/W4205284298

National Institutes of Health

Grant: CIVIC75N93019C00052

National Institutes of Health

Grant: 3R37AI080289-11S1

Defining humoral correlates of immunity against COVID-19

National Institutes of Health

Grant: U19AI42790-01

National Institutes of Health

Grant: U19AI135995-02

National Institutes of Health

Grant: 1U01CA260476 \u2013 01

National Institutes of Health

Grant: R01AI146785

National Institutes of Health

Grant: HHSN272201500002C

National Institutes of Health

Grant: AID AI149644

National Institutes of Health

Grant: UM1AI148684

National Institutes of Health

Grant: UM1AI148576

National Institutes of Health

Grant: UM1AI148373

National Institutes of Health

Grant: P51 OD011132

NASA

Grant: NNX16AO69A

NIAID NIH HHS

Grant: U01 AI149644

NIAID NIH HHS

Grant: U19 AI135995

NIAID NIH HHS

Grant: 75N93019C00052

NIAID NIH HHS

Grant: R01 AI042790

NCI NIH HHS

Grant: U01 CA260476

NIAID NIH HHS

Grant: R37 AI080289

NIAID NIH HHS

Grant: P30 AI060354

National Institutes of Health

Grant: 3U01CA260476-02S2

Immunologic Signatures of SARS-CoV-2 Vaccination and Disease

National Institutes of Health

Grant: 3U19AI135995-04S3

Consortium for Viral Systems Biology (CViSB)

National Institutes of Health

Grant: 3P51OD011132-64S2

Renovation to expand and enhance NHP housing for HIV/AIDS research at the Emory NPRC

National Institutes of Health

Grant: 1U01AI149644-01

Respiratory Virus Vaccine and Adjuvant Exploration

National Institutes of Health

Grant: 3UM1AI148373-02S1

Kaiser Washington Vaccine and Treatment Evaluation Unit

National Institutes of Health

Grant: 7R01AI042790-05

CHLAMYDIA PNEUMONIAE AND MACROPHAGES IN ATHEROSCLEROSIS

National Institutes of Health

Grant: 3UM1AI148684-03S1

Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)

National Institutes of Health

Grant: 5UM1AI148576-02

Vaccine and Treatment Evaluation Units

National Institutes of Health

Grant: 3R01AI146785-02S1

SARS-CoV-2 Variant Testing

Bill and Melinda Gates Foundation

Coalition for Epidemic Preparedness Innovations

Moderna

National Institute of Allergy and Infectious Diseases

Ragon Institute of MGH, MIT and Harvard

FWCI

11.35

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttp://www.cell.com/article/S1074761322000309/pdf

publisherhttp://www.cell.com/article/S1074761322000309/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1074761322000309?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1074761322000309?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.immuni.2022.01.001

Fields of Study

SARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies ResearchAnimal Virus Infections Studies0301 basic medicine03 medical and health sciences2019-nCoV Vaccine mRNA-1273AdultAntibodies, NeutralizingAntibodies, ViralCOVID-19Cross ReactionsFemaleHost-Pathogen InteractionsHumansMaleMiddle AgedNeutralization TestsProtein BindingReceptors, FcSARS-CoV-2Spike Glycoprotein, CoronavirusVaccinationYoung AdultSARS-CoV-2 variants

MeSH Terms

COVID-19SARS-CoV-22019-nCoV Vaccine mRNA-1273AdultAntibodies, ViralCross ReactionsFemaleHumansMaleMiddle AgedNeutralization TestsProtein BindingReceptors, FcVaccinationHost-Pathogen InteractionsYoung AdultAntibodies, NeutralizingSpike Glycoprotein, Coronavirus

Keywords

NeutralizationAntibodyBiologyEffectorVirologyNeutralizing antibodyImmunologyImmune systemReceptorImmunitySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Messenger RNACoronavirus disease 2019 (COVID-19)DiseaseInfectious disease (medical specialty)GeneMedicineGeneticsVaccinesFc Effector FunctionCovid-19Sars-cov-2Variants Of ConcernMrna-1273 VaccinationAdultMaleVaccinationReceptors, FcCross ReactionsMiddle AgedAntibodies, ViralAntibodies, NeutralizingArticleYoung AdultNeutralization TestsHost-Pathogen InteractionsSpike Glycoprotein, CoronavirusHumansFemale2019-nCoV Vaccine mRNA-1273Protein Binding

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern

FAIR Checklist

Authors (19)

Funding (34 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)